Miriam Krugliak
Jerusalem, JM 91904, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 01, 2025
Potent Anti-Influenza Synergistic Activity of Theobromine and Arainosine.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
Viroporins of Mpox Virus.
Journal: International journal of molecular sciences
Published: August 01, 2023
Zika M-A Potential Viroporin: Mutational Study and Drug Repurposing.
Journal: Biomedicines
Published: January 31, 2022
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 25, 2021
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing.
Journal: Viruses
Published: February 16, 2021
Potential Viroporin Candidates From Pathogenic Viruses Using Bacteria-Based Bioassays.
Journal: Viruses
Published: April 30, 2019
Mapping the Resistance Potential of Influenza's H+ Channel against an Antiviral Blocker.
Journal: Journal of molecular biology
Published: May 30, 2016
Computational and experimental analysis of drug binding to the Influenza M2 channel.
Journal: Biochimica et biophysica acta
Published: June 05, 2013
Self-interaction of transmembrane helices representing pre-clusters from the human single-span membrane proteins.
Journal: Bioinformatics (Oxford, England)
Published: May 04, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026